ClinicalTrials.Veeva

Menu

Research on the Enhancement of Aerobic Metabolic Energy Supply Capacity by Ischemic Preconditioning.

Z

Ziyue Ou

Status

Completed

Conditions

Aerobic Capacity
Ischemic Preconditioning

Treatments

Device: Sham
Device: Ischemic Preconditioning

Study type

Interventional

Funder types

Other

Identifiers

NCT07170774
2023WCXTD011

Details and patient eligibility

About

The purpose of this clinical trial is to investigate whether IPC can improve aerobic capacity during exercise. The primary question it aims to answer is: Does IPC enhance the aerobic capacity of athletes? The researchers will compare IPC (220 mmHg pressure) with a placebo (20 mmHg pressure) to see if different interventions can enhance aerobic capacity and exercise performance.

Participants will:

  • Undergo a randomized crossover controlled trial, visiting twice, with a one-week interval between each test.
  • Conduct two assessments at the testing site each time, namely a pre-intervention assessment and a post-intervention assessment.
  • Record their heart rate, blood pressure, weight, oxygen uptake, Taekwondo-specific performance, and other indicators.

Enrollment

16 patients

Sex

Male

Ages

18 to 22 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • adult male athletes aged 18 years or older;
  • taekwondo athletes classified as national second-class or above (having placed in the top three provincial professional taekwondo championships or the top eight national professional taekwondo championships);
  • consistent and unified training over the past three months;
  • no prior ischemic preconditioning;
  • competitive taekwondo athletes.

Exclusion criteria

  • supplementation with creatine;
  • acute or chronic illnesses, including anxiety, depression, cardiovascular diseases, and metabolic disorders;
  • engaging in vigorous physical activity within 48 hours prior to the experiment;
  • consuming alcohol or caffeine within 24 hours before the experiment.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

16 participants in 2 patient groups, including a placebo group

IPC Trial
Experimental group
Description:
220 mmHg
Treatment:
Device: Ischemic Preconditioning
SHAM Trial
Placebo Comparator group
Description:
20 mmHg
Treatment:
Device: Sham

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems